Drug Controller General of India (DCGI)

DCGI orders Serum Institute of India to suspend recruitment for Oxford COVID-19 vaccine trials

DCGI orders Serum Institute of India to suspend recruitment for Oxford COVID-19 vaccine trials

The Drugs Controller General of India (DCGI) Dr VG Somani on Friday ordered the pharma giant Serum Institute of India (SII) to suspend an...Read More

Latest COVID-19 vaccine update: Pune-based Serum Institute gets DCGI nod for clinical trials of Oxford vaccine

Latest COVID-19 vaccine update: Pune-based Serum Institute gets DCGI nod for clinical trials of Oxford vaccine

The Drugs Controller General of India (DCGI) has given approval to Pune's Serum Institute of India (SII) to conduct clinical trials of Ox...Read More

Glenmark defends Covid drug, says it’s economical, effective

Glenmark defends Covid drug, says it’s economical, effective

While the price of the drug by the company is Rs 75 per tablet, in Russia it is Rs 600 per tablet; Japan ( Rs 378), Bangladesh (Rs 350 ) ...Read More

COVID-19 in India: Phase 2 clinical trial of Sun Pharma’s AQCH commences

COVID-19 in India: Phase 2 clinical trial of Sun Pharma’s AQCH commences

Pharmaceutical company, Sun Pharma, has commenced Phase 2 clinical trial on AQCH, a phytopharmaceutical (plant derived) drug for treatmen...Read More

Clinical trials for drug on CoVID-19 to start soon

Clinical trials for drug on CoVID-19 to start soon

Glenmark receives an approval from DCGI; country may get Corona medicine by September

Glenmark Pharma stocks rise nearly 9% on DCGI nod for clinical trials of COVID-19 tablets

Glenmark Pharma stocks rise nearly 9% on DCGI nod for clinical trials of COVID-19 tablets

Shares of Glenmark Pharmaceuticals on Thursday gained nearly 9 per cent after the company said it has received approval from DCGI to cond...Read More

Free Press Journal

www.freepressjournal.in